Inspire Medical SystemsINSP
INSP
About: Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
Employees: 1,246
0
Funds holding %
of 7,296 funds
0
Analysts bullish %
of 7 analysts
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
19% more repeat investments, than reductions
Existing positions increased: 135 | Existing positions reduced: 113
16% more first-time investments, than exits
New positions opened: 59 | Existing positions closed: 51
2.89% more ownership
Funds ownership: 111.42% [Q4 2024] → 114.31% (+2.89%) [Q1 2025]
2% more funds holding
Funds holding: 352 [Q4 2024] → 358 (+6) [Q1 2025]
5% more call options, than puts
Call options by funds: $36.7M | Put options by funds: $34.9M
12% less capital invested
Capital invested by funds: $6.2B [Q4 2024] → $5.45B (-$750M) [Q1 2025]
25% less funds holding in top 10
Funds holding in top 10: 8 [Q4 2024] → 6 (-2) [Q1 2025]
Research analyst outlook
7 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$174
37%
upside
Avg. target
$202
58%
upside
High target
$236
86%
upside
7 analyst ratings
5 positive
71%
2 neutral
29%
0 negative
0%
Morgan Stanley Kallum Titchmarsh | 57%upside $200 | Overweight Maintained | 6 May 2025 |
JP Morgan Robbie Marcus | 53%upside $195 | Overweight Maintained | 6 May 2025 |
Wells Fargo Larry Biegelsen | 37%upside $174 | Equal-Weight Maintained | 6 May 2025 |
Baird Mike Polark | 86%upside $236 | Outperform Maintained | 6 May 2025 |
Stifel Jonathan Block | 38%upside $175 | Hold Maintained | 21 Apr 2025 |
Financial journalist opinion
Based on 4 articles about INSP published over the past 30 days
Neutral
Zacks Investment Research
2 days ago
Is the Options Market Predicting a Spike in Inspire Medical Systems Stock?
Investors need to pay close attention to INSP stock based on the movements in the options market lately.
Positive
Seeking Alpha
6 days ago
Inspire Medical Systems: Investors Should Sleep Better From Here Onwards
Inspire Medical's growth remains strong, with 2025 seen as a transition year due to the Inspire V launch, causing near-term margin volatility. Valuations look more attractive: shares trade at just 4x sales, a significant discount from previous highs, while the business is profitable and growing. Concerns about GLP-1 drugs impacting demand are likely overblown, as these patients were not ideal candidates for Inspire's therapy anyway.
Neutral
GlobeNewsWire
1 week ago
Inspire Medical Systems, Inc. to Present at the Truist Securities MedTech Conference
MINNEAPOLIS, June 03, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Truist Securities MedTech Conference on Tuesday, June 17, 2025. Inspire is scheduled to present at 11:20 a.m.
Neutral
GlobeNewsWire
2 weeks ago
Inspire Medical Systems, Inc. to Participate in the Wells Fargo 2025 MedTech Innovation Spotlight
MINNEAPOLIS, May 30, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will participate in the Wells Fargo 2025 MedTech Innovation Spotlight on Friday, June 13, 2025.
Neutral
GlobeNewsWire
1 month ago
Dr. Jose Jacob Scholarship for Future Doctors Opens Nationwide: A Timely Opportunity to Inspire Medical Students to Address Real-World Healthcare Challenges
OCALA, Fla., May 07, 2025 (GLOBE NEWSWIRE) -- The Dr. Jose Jacob Scholarship for Future Doctors is now officially open for applications, offering a one-time award of $1,000 to undergraduate students across the United States who are committed to pursuing a career in medicine.
Positive
Zacks Investment Research
1 month ago
All You Need to Know About Inspire (INSP) Rating Upgrade to Buy
Inspire (INSP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Positive
Zacks Investment Research
1 month ago
Wall Street Analysts Predict a 39.04% Upside in Inspire (INSP): Here's What You Should Know
The consensus price target hints at a 39% upside potential for Inspire (INSP). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Positive
Zacks Investment Research
1 month ago
INSP Stock Gains Following Q1 Earnings Beat, Gross Margin Contracts
Inspire Medical's first-quarter 2025 performance reflects increased market penetration in existing centers and expansion into new territories and centers, along with strong domestic results.
Neutral
Seeking Alpha
1 month ago
Inspire Medical Systems, Inc. (INSP) Q1 2025 Earnings Call Transcript
Inspire Medical Systems, Inc. (NYSE:INSP ) Q1 2025 Results Conference Call May 5, 2025 5:00 PM ET Company Participants Ezgi Yagci - Vice President of Investor Relations Tim Herbert - President & Chief Executive Officer Rick Buchholz - Chief Financial Officer Conference Call Participants Kallum Titchmarsh - Morgan Stanley David Rescott - Baird Michael Sarcone - Jefferies Shagun Singh - RBC Chris Pasquale - Nephron Research Larry Biegelsen - Wells Fargo Anthony Petrone - Mizuho Financial Group Jon Block - Stifel Brett Fishbin - KeyBanc Capital Markets Michael Polark - Wolfe Research Travis Steed - Bank of America Securities Danielle Antalffy - UBS Robbie Marcus - JPM Adam Maeder - Piper Sandler Richard Newitter - Truist Operator Good afternoon. My name is Dilem and I'll be your conference operator today.
Positive
Zacks Investment Research
1 month ago
Inspire Medical Systems (INSP) Surpasses Q1 Earnings and Revenue Estimates
Inspire Medical Systems (INSP) came out with quarterly earnings of $0.10 per share, beating the Zacks Consensus Estimate of a loss of $0.23 per share. This compares to loss of $0.34 per share a year ago.
Charts implemented using Lightweight Charts™